Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy arising from the liver. ICC makes up about 10% of all cholangiocarcinomas. It arises from the peripheral bile ducts within the liver parenchyma, proximal to the secondary biliary radicals. Histologically, the majority of ICCs...
Background The clinical presentation of patients with congenital hypothyroidism (CH) caused by paired box gene 8 (PAX8) pathogenic variants is variable and PAX8 mutation rates differ significantly among different populations. This study was set to examine the PAX8 mutation spectrum and prevalence among...
英文名称: PAX8 Recombinant Protein (Q02) with GST 总访问: 406 国产/进口: 进口 半年访问: 12 产地/品牌: Abnova 产品类别: 抗体 规格: 10UG 最后更新: 2024-12-5 货号: CAS 号: 参考报价: 3750元 立即询价 电话咨询 [发表评论] [本类其他产品] [本类其他供应商] [收藏] 分享:微信新浪...
1.一种细胞核转录因子PAX8的调节因子,其为抑制组蛋白去乙酰酶的化合物。 2.如权利要求1所述的调节因子,其中所述组蛋白去乙酰酶为I型组蛋白去乙酰酶。 3.如权利要求1-2任一项所述的调节因子,其中所述化合物为小分子化合物,优选为帕比司他、罗米地辛、西达苯胺、伏立诺他、恩替诺特。 4.包含权利要求1-3所述...
关联企业1 担任法定代表人1 担任股东0 担任高管0 所有任职企业1 作为最终受益人1 所属集团0 历史信息 曾担任法定代表人 曾担任股东 曾担任高管 所有曾任职企业 曾为最终受益人0 历史控股企业0 投资信息 控股企业0 间接持股企业0 爱企查图谱 任职全景图 股权穿透图 商业关系图 风险关注 司法案件0 失信被...
分析Pax8,Pax1蛋白表达与宫颈癌临床病理特征的关系,并采用Cox比例风险回归分析影响宫颈癌患者预后的相关因素.结果观察组Pax8,Pax1蛋白阳性表达率显著高于对照组(68.75%vs 35.00%,70.00%vs 36.25%,P<0.01).Pax8与Pax1蛋白表达在不同宫颈癌肿瘤分期,不同分化程度,有无淋巴结转移,不同浸润深度差异有统计学意义(P<...
目前张颂凯是6家企业最终受益人,包括其在投资江西湘鑫建材科技有限公司最终收益股份为71%,投资江西雅州恺萨新材料科技有限公司最终收益股份为71%等;三、张颂凯的商业合作伙伴:基于公开数据展示,张颂凯目前有6个商业合作伙伴,包括黄轶文、张吉林、肖灼桃等。
PAX8 immunohistochemistry using the MRQ-50 antibody was performed in whole tissue slides (n = 147) or tissue microarray sections (n = 35). We found PAX8 expression in 54.4% of the cases, which was significantly lower than those reported in prior studies with the polyclonal antibody. PAX8 ...
CONTEXT. PAX8 is a transcription factor required for thyroid development, and its mutation causes congenital hypothyroidism (CH). More than 20 experimentally verified loss-of-function PAX8 mutations have been described, and all but one were located in the DNA-binding paired domain. OBJECTIVE. We re...
孙爱弟目前担任嘉兴松发信息咨询有限公司法定代表人,同时担任浙江俊成控股有限公司监事,嘉兴松发信息咨询有限公司执行董事兼总经理;二、孙爱弟投资情况:孙爱弟间接持股企业9家,包括投资上海松发合金材料有限公司、投资占比达41.5%,浙江松发复合新材料有限公司、投资占比达29.88%等;目前孙爱弟是7家企业最终受益人,包括其...